Mackenzie Financial
CELL

Mackenzie Financial’s PhenomeX Inc. Common Stock CELL Stock Holding History

Mackenzie Financial’s Portfolio CELL Stock Details CELL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-4,152,031
Closed -$4.14M – 1620
2023
Q3 		$4.14M Hold
4,152,031
– – 0.01% 577
2023
Q2 		$2.08M Sell
4,152,031
-16,570
-0.4% -$13.6K ﹤0.01% 718
2023
Q1 		$4.84M Hold
4,168,601
– – 0.01% 561
2022
Q4 		$11.2M Sell
4,168,601
-12,572
-0.3% -$33.1K 0.02% 392
2022
Q3 		$12M Sell
4,181,173
-21,074
-0.5% -$89.6K 0.02% 388
2022
Q2 		$20.9M Buy
4,202,247
+795
+0% +$4.17K 0.03% 320
2022
Q1 		$29.9M Buy
4,201,452
+1,161,295
+38% +$9.61M 0.04% 286
2021
Q4 		$55.3M Buy
3,040,157
+767,216
+34% +$16.6M 0.07% 230
2021
Q3 		$44.5M Buy
2,272,941
+1,726,872
+316% +$65.7M 0.06% 241
2021
Q2 		$24.5M Buy
+546,069
New +$25.3M 0.03% 309

Mackenzie Financial's CELL Position: Q4 2023 in Review

Mackenzie Financial sold out of PhenomeX Inc. Common Stock (CELL) in Q4 2023, closing a stake of 4,152,031 shares — an estimated $4.14M sold.

Mackenzie Financial first reported a position in CELL in Q2 2021 and held it in 10 quarters. The position peaked at $55.3M in Q4 2021. 0 funds tracked by Wall St. Rank hold CELL as of Q4 2023.

  • Mackenzie Financial reported no remaining PhenomeX Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Mackenzie Financial sold 4,152,031 PhenomeX Inc. Common Stock shares in Q4 2023, an estimated $4.14M.
  • Mackenzie Financial first reported a position in PhenomeX Inc. Common Stock in Q2 2021 and held it in 10 quarters.
  • Mackenzie Financial's PhenomeX Inc. Common Stock position peaked at $55.3M in Q4 2021.
  • 0 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q4 2023.

Based on Mackenzie Financial's 13F filing for Q4 2023, filed 30 Jan 2024.